JC virus viremia in interferon-β –treated and untreated Italian multiple sclerosis patients and healthy controls
- 1 January 2007
- journal article
- Published by Springer Science and Business Media LLC in Journal of NeuroVirology
- Vol. 13 (1), 73-77
- https://doi.org/10.1080/13550280601094563
Abstract
Following the development of progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis (MS) patients treated with natalizumab and interferon-β (IFNβ), a possible correlation between JC virus (JCV), the etiological agent of PML, and MS has received heightened interest. In particular, attention has focused on assessing whether IFNβ treatment could affect the replication of JCV and thus its frequency in the peripheral blood of MS patients and whether the presence of JCV DNA in peripheral blood could be a predictive marker of the risk of developing PML. In order to answer to these questions, peripheral blood samples were collected from 59 INFβ-treated, 39 untreated relapsing-remitting MS patients, and 98 healthy controls (HCs) and JCV DNA levels were determined and quantified by means of a real-time polymerase chain reaction (Q-PCR) assay. Overall, no differences were found in the presence or viral load of JCV DNA of MS patients and the HCs, but JCV DNA was significantly less frequent in the peripheral blood of IFNβ-treated patients (13.6%) compared to the untreated MS patients (46.1%) and the healthy controls (28.6%). These results suggest that the presence of JCV in the blood of MS patients cannot be considered as a marker or a risk factor for PML development. In addition, they indicate that treatment with INFβ can lead to the reduction of presence of the JCV genome in the peripheral blood of MS patients and, thus, that this drug probably does not increase the risk of PML in MS patients treated with IFNβ.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of Patients Treated with Natalizumab for Progressive Multifocal LeukoencephalopathyThe New England Journal of Medicine, 2006
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisThe New England Journal of Medicine, 2005
- Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis.2005
- A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urineJournal of NeuroVirology, 2005
- Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individualsJournal of NeuroVirology, 1999
- Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathyJournal of Medical Virology, 1997
- Interaction of the human polyomavirus, JCV, with human B-lymphocytesVirology, 1992
- Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathyAnnals of Neurology, 1992
- CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHYThe Lancet, 1971
- Polyoma-like virions in a human demyelinating diseaseActa Neuropathologica, 1967